House Resolution 233 is a commemorative resolution that designates February 3, 2026 as Topical Steroid Withdrawal Syndrome Awareness Day in Illinois. The resolution describes topical steroid withdrawal syndrome (TSWS), also called topical steroid addiction or red skin syndrome, as a serious condition that can follow intentional or unintentional use of topical steroids and may cause severe skin inflammation, burning, itching, flaking, and prolonged recovery periods.
The resolution emphasizes that TSWS can have major physical, emotional, and social effects, including inability to work, attend school, or care for children, and it cites reported rates of anxiety, depression, and suicidal ideation among affected adults and children. It also notes that the condition is under-researched, that the lack of published research makes diagnosis and treatment difficult, and that limited awareness can create misunderstandings between patients and providers. The resolution calls for greater education and prevention efforts regarding the signs of topical steroid dependence and the risks of TSWS.
Impact
HR0233 does not amend the Illinois Compiled Statutes or create regulatory requirements; it is a House resolution establishing an awareness day. Its practical effect is symbolic and educational, intended to elevate public and professional awareness of TSWS, encourage research and provider education, and support patients and families affected by the condition. The resolution may influence public health outreach and advocacy, but it does not directly change prescribing rules, insurance coverage, or medical practice standards.
Sentiment
The overall sentiment reflected in the resolution is supportive and sympathetic toward patients experiencing TSWS. The bill frames the condition as serious, under-recognized, and deserving of public attention, and it presents awareness as beneficial to both patients and providers. Because there are no recorded committee transcripts or votes in the provided context, there is no evidence of formal opposition or divided sentiment in the available record.
Contention
The main points of concern identified in the resolution are not legislative disputes but medical and informational gaps: the scarcity of research, uncertainty about prevalence, difficulty defining diagnostic criteria, and lack of awareness among both patients and providers. The resolution suggests these gaps can lead to friction, including patients doubting medical oversight and providers suspecting non-compliance or even parental neglect. No specific lawmakers, committees, or stakeholder groups are shown as opposing the measure in the provided materials.